Choosing Between Moderate Therapies for Mild/Moderate Multiple Sclerosis


Key opinion leaders share their approach to treatment sequencing for patients with multiple sclerosis (MS), taking into account comorbidities such as cardiovascular diseases, risk of infection, liver damage, and cancer as well as considering factors like planned pregnancy or advanced age.

Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.